Virtus LifeSci Biotech Products ETF
12 hedge funds and large institutions have $4.74M invested in Virtus LifeSci Biotech Products ETF in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 13 → 12 (-1)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$202K | |
| 2 | +$168K | |
| 3 | +$89.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$14.8K |
| 5 |
Morgan Stanley
New York
|
+$12K |
Top Sellers
| 1 | -$210K | |
| 2 | -$120K | |
| 3 | -$28.5K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$6.28K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$314 |